Considerable effort has been devoted to optimizing nanoplatforms by overcoming tumor hypoxia using nanoplatforms with O2 carriers (Hb and non-Hb) and generators (catalase, water splitting, and metals) by nanozymes [12–15]. This evidence concerns the gene GSTM1 and neoplasm.